(Q44255828)

1 December 2017

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients (English)

1 reference

1 December 2017

0 references

0 references

Weiss RA

1

1 reference

1 December 2017

Clapham PR

2

1 reference

1 December 2017

Cheingsong-Popov R

3

1 reference

1 December 2017

Dalgleish AG

4

1 reference

1 December 2017

Carne CA

5

1 reference

1 December 2017

Weller IV

6

1 reference

1 December 2017

Tedder RS

7

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 July 1985

1 reference

1 December 2017

1 reference

1 December 2017

316

1 reference

1 December 2017

69-72

1 reference

1 December 2017

6023

1 reference

https://scigraph.springernature.com/pub.10.1038/316069a0

1 December 2017

0 references

cites work

Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome

1 reference

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

21 January 2018

1 reference

7 January 2021

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1 reference

7 January 2021

Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS

1 reference

7 January 2021

Serological Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDS

1 reference

7 January 2021

Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.

1 reference

7 January 2021

Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain

1 reference

7 January 2021

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

7 January 2021

Detection of lymphocytes producing a human retrovirus associated with adult T-cell leukemia by syncytia induction assay

1 reference

7 January 2021

Human T-cell leukemia virus type I: induction of syncytia and inhibition by patients' sera

1 reference

7 January 2021

Pseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera

1 reference

7 January 2021

Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS

1 reference

7 January 2021

HTLV-III serology distinguishes atypical and endemic Kaposi's sarcoma in Africa

1 reference

7 January 2021

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

1 reference

7 January 2021

Molecular Characterization of Human T-Cell Leukemia (Lymphotropic) Virus Type III in the Acquired Immune Deficiency Syndrome

1 reference

7 January 2021

Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).

1 reference

7 January 2021

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex

1 reference

7 January 2021

Leukosis and Marek's disease viruses of feral red jungle flow and domestic fowl in Malaya

1 reference

7 January 2021

Epitopes of bovine leukemia virus glycoprotein gp51 recognized by sera of infected cattle and sheep

1 reference

7 January 2021

Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus

1 reference

7 January 2021

Virus Mutation during 'Slow Infection': Temporal Development and Characterization of Mutants of Visna Virus recovered from Sheep

1 reference

7 January 2021

Antigenic variation in visna virus

1 reference

7 January 2021

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

1 reference

7 January 2021

Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions

1 reference

7 January 2021

Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of CTL-target cell binding

1 reference

7 January 2021

Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in London

1 reference

7 January 2021

Antibody to lymphadenopathy-associated virus in AIDS.

1 reference

7 January 2021

Deficient LAV1 neutralising capacity of sera from patients with AIDS or related syndromes

1 reference

7 January 2021

Identifiers

DOI

10.1038/316069A0

1 reference

Dimensions Publication ID

1 December 2017

0 references

1 reference